HENDERSON, Nev.--(BUSINESS WIRE)--Quertle LLC has developed the first artificial intelligence and visual analytics big data (BioAI™) platform for biomedical drug discovery. This platform combines ...

Quris Technologies Ltd. has inked an agreement with Merck KGaA to assess its BioAI safety prediction platform. The partnership will compare the Quris’ artificial intelligence (AI)-based platform with ...

As of February 28 at 1:26:00 AM UTC. Market Open. A ratio that indicates liquidity. Higher ratios suggest the asset is more actively traded and easier to buy/sell near its true value. Lower ratios may ...

Artificial intelligence is being positioned as a catalytic force in reshaping biomanufacturing, with policymakers, scientists and industry leaders outlining a roadmap that blends computational power ...

Quris Technologies Ltd. (Quris-AI) and Merck KGaA have extended their collaboration after a successful initial preclinical study of Quris-AI’s BioAI drug safety platform.

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic candidates as ...

Arbele, a leading innovator in biopharmaceutical and biotechnology focused on targeting cadherin-17 (CDH17), has announced a strategic collaboration in precision oncology using artificial intelligence ...

AI has crossed a threshold. It is no longer a frontier technology confined to pilots and prototypes. It is beginning to shape real outcomes—credit access, welfare delivery, healthcare triage, language ...

As of February 28 at 1:26:00 AM UTC. Market Open.